The Expenditures for Academic Inpatient Care of Inflammatory Bowel Disease Patients Are Almost Double Compared with Average Academic Gastroenterology and Hepatology Cases and Not Fully Recovered by Diagnosis-Related Group (DRG) Proceeds-Reference-Cited by-同舟云学术

The Expenditures for Academic Inpatient Care of Inflammatory Bowel Disease Patients Are Almost Double Compared with Average Academic Gastroenterology and Hepatology Cases and Not Fully Recovered by Diagnosis-Related Group (DRG) Proceeds

Published:2016-01-19 Issue:1 Volume:11 Page:e0147364
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Baumgart Daniel C.,le Claire Marie

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Crohn's disease;DC Baumgart;Lancet,2012

2. Ulcerative colitis;S Danese;N Engl J Med,2011

3. Systematic review: the costs of ulcerative colitis in Western countries;RD Cohen;AlimentPharmacolTher,2010

4. The costs of Crohn's disease in the United States and other Western countries: a systematic review;AP Yu;CurrMedResOpin,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction and maintenance of mucosal healing in Crohn’s disease with ustekinumab in clinical practice across all care levels in Germany (MUCUS);Scientific Reports;2024-09-03

2. DRGKB: a knowledgebase of worldwide diagnosis-related groups’ practices for comparison, evaluation and knowledge-guided application;Database;2024

3. DRGKB: A Knowledge Base and Platform for Comparison, Evaluation and Worldwide Practices of Diagnosis-Related-Groups;SSRN Electronic Journal;2022

4. Krankheitskosten chronisch entzündlicher Darmerkrankungen in Deutschland;Zeitschrift für Gastroenterologie;2020-08-31

5. Experiences of using vedolizumab in the treatment of inflammatory bowel disease in the East Midlands UK – a retrospective observational study;Scandinavian Journal of Gastroenterology;2020-07-11